Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2004
02/18/2004CN1476322A Use of cyclosporin A7-thioamide derivatives for hair growth
02/18/2004CN1476318A O/W emulsion composition and method of preparing same
02/18/2004CN1475765A Grouping drying device for preparing Chinese and western medicine pill, pellet and its technology
02/18/2004CN1475275A Mannan peptide freeze dried powder ampoule for injection
02/18/2004CN1475269A Rhizoma cimicifugae extract and its preparation method
02/18/2004CN1475267A Sanshe wind-dispelling plaster
02/18/2004CN1475266A Production method of injection agent used for treating cardio and cerebro vascular diseases and its product
02/18/2004CN1475262A Medicine for treating asynodia and prospermia
02/18/2004CN1475261A Medicine for treating gastral cavity pain and its preparation method
02/18/2004CN1475259A Compound ganmaoling tablet (film coating tablet for treating common cold) and its manufacturing method
02/18/2004CN1475258A Compound dantong tablet (film coating tablet for disorder of gallbladder) and its manufacturing method
02/18/2004CN1475257A Medicinal plaster for treating chololithiasis
02/18/2004CN1475256A Medicinal plaster for treating urolithiasis
02/18/2004CN1475255A Medicinal plaster for treating algomenorrhea and regulating menstrual function
02/18/2004CN1475254A Medicine for treating coronary disease and stenocardia and its preparation method
02/18/2004CN1475253A Quick effect toothache plaster
02/18/2004CN1475242A Preparation method of ginkgo leaf extract freeze dried powder injection
02/18/2004CN1475239A Chinese herbal medicine plaster and its processing technology
02/18/2004CN1475226A Application of nano copper powder in preparation of antisenility medicine
02/18/2004CN1475225A Use of Bacille Calmette-Guerin polysaccharide nucleic acid in the preparation of medicine for oral cavity local administration
02/18/2004CN1475222A Vine leaf extract and its preparation process
02/18/2004CN1475221A Luerythromycin oculentum
02/18/2004CN1475219A Medicinal composition for treating blood vessel disease
02/18/2004CN1475216A Egg yolk lecithin soft capsule and its production process
02/18/2004CN1475215A Enosaxin for injection and its preparation method
02/18/2004CN1475213A Soyisoflavone soft capsule and its preparation technology
02/18/2004CN1475209A Slow-released agent form of sertraline
02/18/2004CN1475208A Slow-released agent form of sertraline
02/18/2004CN1475207A Solid oral dosage mode containing walshaden and hydrochloric thizaine
02/18/2004CN1475206A Medical composition containing micropowdery bicyclic medicine
02/18/2004CN1475205A Medicine conveying system--preparation method of solid nano medicine
02/18/2004CN1475204A Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method
02/18/2004CN1475203A Coloured plaster and its preparation method
02/18/2004CN1138591C Coated particles, method of making and using
02/18/2004CN1138579C Diffusional implantable delivery system
02/18/2004CN1138561C Chewing gum for preventing decayed tooth and its preparing process
02/18/2004CN1138559C Pill medicine for treating cardio-cerebro vascular diseases
02/18/2004CN1138552C Polyphenol extract of tea, use thereof and formulations containing same
02/18/2004CN1138550C Process of producing extracts of shark
02/18/2004CN1138547C Hormonal medicaments for correcting oestrogen deficiencies
02/18/2004CN1138543C Lyophilizate of lipid complex of water insoluble camptothecins
02/18/2004CN1138542C Method for stabilizing pharmaceutical composition by special use of antioxidant
02/18/2004CN1138541C Pharmaceutically stable oxaliplatinum prepn.
02/18/2004CN1138537C Probucol clathrate capsule and its prepn. process
02/18/2004CN1138536C Oil/water fat emulsion or its application of freeze dry composition
02/18/2004CN1138535C Pharmaceutical compositions contg. effervescent acid -base couple
02/18/2004CN1138534C Multiple unit tableted dosage
02/18/2004CN1138533C Liposomes
02/18/2004CN1138532C Pharmaceutical aerosol composition
02/18/2004CN1138531C Dispersible macromolecule compositions and method for their preparation and use
02/18/2004CN1138530C Liquid ophthalmic sustained release delivery system
02/18/2004CN1138529C Fizzy formulation
02/18/2004CN1138528C Peptide/protein suspension temper
02/18/2004CN1138527C Osmotic device with delayed activation of drug delivery and complete drug release
02/18/2004CN1138526C Intravaginal drug delivery devices for administration of 17 beta-oestradiol precursors
02/18/2004CN1138519C Nano-emulsion contaning alkoxyalkenyl or glucose alkoxyalkenyl succinate and uses in cosmetics and pharmaceutics
02/18/2004CN1138505C Anti-angiogenic compositions and method of use
02/17/2004US6694191 Ambulatory medical apparatus and method having telemetry modifiable control software
02/17/2004US6693208 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability
02/17/2004US6693135 Prostaglandin compositions and methods of treatment for male erectile dysfunction
02/17/2004US6693129 A biochemical formulation comprising ascorbic acid, niacin, lysine, and proline useful for lowering plasma concentration of a lipoprotein in mammal
02/17/2004US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
02/17/2004US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
02/17/2004US6693086 Eliciting nonantigen and strong antigen specific immune response; cancer, allergic inflammation and/or infectious disease prevention
02/17/2004US6692775 Bactericidal gel and method for treating burns and dermal lesions
02/17/2004US6692773 Treatment of hyperproliferative skin disorders and diseases
02/17/2004US6692771 Emulsions as solid dosage forms for oral administration
02/17/2004US6692770 Suitable for parenteral administration, preferably via injection comprising amylopectin
02/17/2004US6692769 Drug-containing core coated with a mixture of a hydrophobic organic compound-water-insoluble polymer, which prevents sticking during compression molding when producing oral sustained release tablets
02/17/2004US6692768 Spherical fine particles that are useful in the production of easily-swallowed, controlled-release preparations having a mean particle size of 60-200 mu m
02/17/2004US6692767 Solid solution beadlet
02/17/2004US6692766 For increasing the bioavailability of orally administered drugs belonging to the following categories: large molecular weight drugs, drugs that lose their potency in the gastrointestinal tract as a result of enzymatic degradation
02/17/2004US6692765 Exactly divisible tablet
02/17/2004US6692764 Treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and metastatic bone disease; binder-free tablets
02/17/2004US6692763 Equivalent to a serum estadiol level not exceeding of between about 5 pg/ml and about 15 pg/ml, for treatment of physical conditions associated with menopause: hot flashes; bone loss; headache; nausea etc.
02/17/2004US6692762 Generating linoleic acid derivatives; obtain chemical intermediates, incubate with lipase, recover fatty acid conjugated to linoleic acid
02/17/2004US6692759 Dissolving biocompatible polymer in suitable solvent solution, adding chemical substance, drying mixture, refrigerating dry mass
02/17/2004US6692755 Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
02/17/2004US6692734 N,O-amidomalonate platinum complexes
02/17/2004US6692695 Vacuum drying solution or suspension by mixing to boiling without freezing; heat exchanging; monitoring; storage stable viruses and cells
02/17/2004US6692457 Flow condition sensor assembly for patient infusion device
02/17/2004US6691457 Floral packaging material having great masters prints thereon
02/17/2004CA2408585C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
02/17/2004CA2290969C Delayed-release dosage forms of sertraline
02/17/2004CA2268908C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea)
02/17/2004CA2183755C Pharmaceutical preparation containing plasminogen activators
02/17/2004CA2145505C Microparticle preparations made from biodegradable copolymers
02/17/2004CA2074348C Stable compositions for parenteral administration and their use
02/14/2004CA2454644A1 Cannabinoid liquid formulations for mucosal administration
02/13/2004CA2437064A1 Storage-stable, liquid fibrinogen formulation
02/13/2004CA2395819A1 Dual-spike release formulation for oral drug delivery
02/12/2004WO2004013605A2 Nanoparticles comprising a mixed monolayer for specific ligand binding
02/12/2004WO2004013310A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna
02/12/2004WO2004012855A2 Ethylene glycol monolayer protected nanoparticles
02/12/2004WO2004012795A2 Methods of delivering therapeutic agents
02/12/2004WO2004012791A2 Improved injection system
02/12/2004WO2004012772A1 Oral administration of calcitonin
02/12/2004WO2004012771A1 Pharmaceutical compositions comprising cyclosporin for oral administration
02/12/2004WO2004012770A1 Oral pharmaceutical compositions comprising cyclosporin
02/12/2004WO2004012751A1 Bacterial cell wall skeleton component preparaion